Patents by Inventor Jack Gemmell

Jack Gemmell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized antibody
    Publication number: 20050226883
    Abstract: Novel humanized and chimeric antibodies, humanized antibody fragments, polypeptides sequences of such antibodies and derivatives thereof that specifically bind AF-20 are provided as well as methods for their manufacture. These humanized and chimeric antibodies, antibody fragments and polypeptide sequences are useful in the treatment of cancers that express AF-20, as well as for diagnostic purposes, e.g., for in vivo imaging of tumors or cancer cells that express AF-20.
    Type: Application
    Filed: February 4, 2005
    Publication date: October 13, 2005
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Publication number: 20050032704
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Application
    Filed: October 12, 2004
    Publication date: February 10, 2005
    Applicant: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Publication number: 20030166569
    Abstract: The invention is directed to methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds containing or based on peptides comprising a part of the amino acid sequence of a neural thread protein.
    Type: Application
    Filed: November 15, 2002
    Publication date: September 4, 2003
    Inventors: Paul Averback, Jack Gemmell
  • Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
    Publication number: 20030109437
    Abstract: The present invention relates to peptides, compositions, and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such proteins), the amino acid sequence of which includes at least one amino acid sequence derived from neural thread proteins and other related molecules.
    Type: Application
    Filed: July 19, 2002
    Publication date: June 12, 2003
    Inventors: Paul Averback, Jack Gemmell
  • Bacteriophage composition useful in treating food products to prevent bacterial contamination
    Patent number: 6461608
    Abstract: The present invention is directed to novel bacteriophage compositions useful in treating food products to prevent bacterial contamination.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: October 8, 2002
    Assignee: Nymox Pharmaceutical Corporation
    Inventors: Paul Averback, Jack Gemmell